Philadelphia University + Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Falkner, Bonita

< Back

Profile

bxf106

Bonita Falkner, MD

Contact Dr. Falkner

833 Chestnut Street
Suite 700
Philadelphia, PA 19107

(215) 955-6550
(215) 955-5034 fax fax

Medical School

University of Minnesota - 1967

Residency

Philadelphia General Hospital

Fellowship

Thomas Jefferson University Hospital

Board Certification

Pediatric Nephrology
Pediatrics

Hospital Appointment

Thomas Jefferson University Hospital

Research Interests

Research interests include the genetic basis of essential hypertension, insulin resistance and obesity

Publications

Most Recent Peer-Reviewed Publications

  1. Ambulatory hypertension in a pediatric cohort of sickle cell disease
  2. The Childhood Role in Development of Primary Hypertension
  3. Neurocognitive Function in Children with Primary Hypertension after Initiation of Antihypertensive Therapy
  4. The enigma of blood pressure measurement in children with CKD
  5. Changes in the 2017 Pediatric Hypertension Clinical Guidelines
  6. Development of blood pressure norms and definition of hypertension in children
  7. Insulin resistance and other mechanisms of obesity hypertension
  8. Monitoring and management of hypertension with obesity in adolescents
  9. New Clinical Practice Guideline for the Management of High Blood Pressure in Children and Adolescents
  10. Clinical practice guideline for screening and management of high blood pressure in children and adolescents
  11. Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males
  12. Does Potassium Deficiency Contribute to Hypertension in Children and Adolescents?
  13. Hypertension in chronic kidney disease
  14. Uremia induces adipose tissue inflammation and muscle mitochondrial dysfunction
  15. Neurocognitive Function in Children with Primary Hypertension
  16. Association of inflammation prior to kidney transplantation with post-transplant diabetes mellitus
  17. Is the SPRINT blood pressure treatment target of 120/80 mm Hg relevant for children?
  18. Cardiometabolic risks related to obesity severity in children and adolescents: A commentary
  19. Is there a bend in the upward trend of high blood pressure in childhood? A commentary on prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012
  20. Treatment-induced changes in plasma adiponectin do not reduce urinary albumin excretion in the diabetes prevention program cohort